Medicine Runners: A community-initiated solution to chronic medicine access in underserved communities by Boswell, Dominique et al.
 2018 Vol 85 No 4S Afr Pharm J 64
OPINION PAPER
Introduction
South Africa’s  quadruple burden of disease imposes a strain on 
the public health system, with patients affected by communicable 
and non-communicable chronic diseases requiring chronic 
medication therapy. In this regard, access to a continuous supply 
of medicines is crucial to reach equitable and quality health access 
for all South Africans as envisioned through universal health 
coverage (UHC) as per the National Health Insurance (NHI).1
In comparison to the private health sector, pharmaceutical 
services in the public health sector operate with severe 
resource limitations to address the pharmaceutical needs of 
an increasing patient load. In an effort to decrease the patient 
load on facilities, the centralised chronic medicine dispensing 
and distribution (CCMDD) programme was implemented.2 This 
would have a twofold solution for facility-based pharmaceutical 
service delivery: (1) the pre-packing of chronic medication from 
repeat prescriptions at an off-site dispensary (thus lightening 
the load on pharmacists at facilities); and (2) the distribution of 
these chronic medicine parcels at alternative distribution points 
outside the facility (thus reducing the number of patients queuing 
at the pharmacy). There is thus a need for pharmacists to better 
understand medicine use in the community to align with the new 
model of service delivery.
The School of Pharmacy at the University of the Western Cape 
(UWC) is committed to exposing students to the realities 
of medicine use in underserved communities. This is done 
through the bi-annual SLiP programme embedded in the first 
to the third years of study, which places students in a range of 
learning environments such as informal settlements, primary 
healthcare clinics, community healthcare centres and hospitals. 
Such exposure aims to prepare students to make sense of the 
community perspective on medicine use and access. 
A Community Engagement (CE) elective introduced in the fourth 
year (2018) aims to sensitise students to a role in advocating for 
social justice and the future pharmacists’ role as a “change agent” 
in resource-constrained settings.3 The co-authors of this open 
forum article are six final year pharmacy students, enrolled for the 
2018 CE elective. The students’ first CE activity was to participate 
in the School’s Medicine Runners Workshop (February 2018) to 
engage meaningfully with role-players to understand the role of 
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Patient access to chronic medicines is crucial in optimising disease management. With the introduction of a decentralised chronic 
dispensing unit, stable patients qualify to have access to their chronic medicines away from health facilities at alternative distribution 
points in the community. The aim of such decentralised chronic medicine ‘parcel’ collection points is to minimise patient load at 
healthcare facilities. However, non-collection of medicine parcels creates added workload for pharmacy staff and poses a financial 
burden on the health system.
At the University of the Western Cape, following a workshop with community members as part of the service learning in pharmacy 
(SLiP) programme (2017), medicine runners (collectors) emerged as a theme. Medicine runners are a community-initiated solution 
to deliver chronic medicine parcels closer to the homes of vulnerable patients. They are community members who fetch medicine 
parcels either from the facility, or from a collection point, for delivery closer to the patient’s home. 
Final year pharmacy students (n=6) participated in the workshop to engage with various role-players (n=19) to ascertain how the 
medicine runners services could be regulated within existing pharmaceutical services. Students were further concerned about 
the integrity of the medicines during delivery. Upon reflection, students felt that reciprocal accountability between the pharmacy 
professionals and medicine runners should be incorporated into the delivery framework. Evidence from a pharmacy alumnus who 
shared experiences on innovative community-based delivery interventions, exemplified adherence to good pharmacy practice rules.
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medicine runners within the health system (UWC BPharm IV CE 
elective 2018). This workshop was born from needs identified 
through the service learning co-operative partnership with the 
Cape Metropole Community Health Forum (CHF) representatives 
(October 2017). 
The CHF was established in accordance with the National Health 
Act,4 which makes provision for provincial health departments 
to establish clinic committees where the community and facility 
can interact regarding community health issues. However, the Act 
failed to specify a formal mandate for health/clinic committees, 
because the roles and functions of these committees were left to 
the provinces to stipulate. The latest amendment by the Western 
Cape government to the Western Cape Health Facility Boards and 
Committees Act (no 4 of 2016), elicited a march to the Western 
Cape legislature to show the community’s discontent with the 
new Act which essentially ignores existing health committees 
and creates a space for new health committees to be appointed 
by the Health MEC.5 The participating CHF representatives are 
community leaders who have long represented the community 
in the health committees and have served to address barriers 
to the provision of quality care at the primary level of care. They 
identified key medicine-related priority needs, in particular 
the emerging role of medicine runners in the community as a 
means to resolve barriers to medicine access among vulnerable 
residents such as the elderly and severely debilitated patients. This 
prompted the question: how is this community-initiated solution 
translated within the regulated pharmaceutical processes of the 
health system? 
The purpose of this open forum article is to reflect on the workshop 
from the perspective of pharmacy students, identify the lessons 
that were learnt and share key messages to inform pharmacy 
education and practice. Workshop participants consisted of 
various role-players either involved in pharmaceutical services 
or medicine use and included public sector pharmacists (n=4), 
practising and research pharmacists (n=1), postgraduate pharmacy 
students (n=2), community health forum representatives (n=10), 
medicine runners (n=1), advocacy representatives (n=1), not-
for-profit organisation representatives (n=2), pharmacy students 
(n=6), academic facilitators (n=2) and public health faculty (n=2). 
Workshop themes 
The emergent workshop themes focused on: (1) the current model 
of care, namely decentralised chronic dispensing of medicine 
parcels and the challenges of this model; (2) the different variations 
of the community-initiated solution, i.e. medicine runners; and (3) 
concerns of different groups of participants regarding the quality 
of medicine runner services. The article concludes with lessons 
and questions, and closes with four key messages from the 
students’ perspective. 
Description of the current model of care
A chronically stable patient receives a six-month repeat 
prescription, which is forwarded from the health facility’s 
administrators to an external private company, also known as 
the chronic dispensing unit (CDU). The CDU is contracted to 
compile and distribute chronic medicine parcels to the facility 
or an alternative distribution point. Essentially this decentralised 
distribution service aims to provide an alternative care model 
to stable chronic patients to bypass the overburdened facility-
based approach with the intention to decrease waiting times, 
and pressure on the healthcare workers and the health system. 
It allows more time for healthcare professionals to serve unstable 
chronic and acute in-patients, as stable patients would be required 
to return for their follow-up to the facility six months later. 
Workshop participants identified two main challenges in the new 
model of care: (1) stock-outs of medicine in medicine parcels; 
and (2) non-collection of medicine parcels. From a patient’s 
perspective, medicine parcels which have missing medicines 
due to stock supply shortages, theft or dispensing error, require 
patients to return to the facility to seek assistance. On the other 
hand, pharmacist participants identified non-collection of chronic 
medicines to cause a huge financial burden on the health system. 
Additional time and staff were required daily to address the 
lack of medicine collection, and address those patients who did 
receive their medicine parcel, but with the absence of one or two 
medicines. Indeed, the problem of stock-outs and non-collection 
was so prevalent that in some clinics a dedicated pharmacist’s 
assistant is specifically assigned to handle chronic medicine 
delivery queries to reduce patient frustration levels.
Medicine runners
A community-initiated solution, namely the medicine runner, 
emerged to enable vulnerable residents to access their chronic 
medicines from alternative distribution points closer to their 
home. Medicine runners or medicine collectors are people who 
are formally and informally identified by the patients (community) 
to collect their chronic medicine parcels from either a health 
facility or an alternative distribution point on behalf of the patient. 
This alternative chronic medication delivery invariably aims to 
minimise non-collection from healthcare facilities or at collection 
points. 
There seem to be a few variations on the community-based 
concept of medicine runner. The first consists of an informal 
community-appointed local resident who undertakes the 
collection of chronic medicine for distribution to patients who are 
unable to access the facility or alternative distribution point on 
the specified day. Medicine parcels with patient reference details 
can then be collected from the medicine runner’s home, which is 
closer than the alternative distribution point or facility.
The second refers to a much larger and formal partnership between 
the community-led medicine delivery services (courier) with a 
private company (Iyeza Health®). Started by a young entrepreneur 
Sizwe Nzima, and co-founded by pharmacist Siraaj Adams,6 the 
establishment of a prominent partnership led to a medicine courier 
service dedicated to over 3 000 people in Cape Town’s underserved 
Khayelitsha’s sub-district. This multi-sectoral collaboration offers 
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doctors, clinics, hospitals and patients an accessible alternative to 
accessing their medications. Job creation was a spin-off for a team 
of seven local residents who are employed, with a bicycle-rider-
to-patient ratio peaking at 1:700 per month (Iyeza Health®). By 
applying the principles of good pharmacy practice, along with the 
legal and ethical requirements, the medicine courier service pilot 
project is expected to disseminate findings to the Department of 
Health. Typically, medicine delivery services are known to levy a 
minimal (approximately R20.00 to R30.00 per parcel) fee. 
The third medicine runner variation is a clinic-based intervention 
into chronic medicine delivery. For example, in a certain 
underserved area, communities relied on the voluntary 
counselling and testing (VCT) counsellor to access their chronic 
medicines directly from public sector facilities. The VCT counsellor 
seemed to serve a dual purpose both in medicine delivery and 
ensuring that patients were treatment-adherent. 
Concerns
Participants’ key concerns related to the medicine runners’ safety 
while travelling, ensuring medicine stability during the delivery 
process, and the uncertain role of the community health forum 
representatives. 
Participants expressed concern for communities, which are riddled 
with gangsters or drug lords, compromising the medicine runners’ 
service. The medicine runners’ safety may be compromised during 
delivery when gangsters are instructed to intercept medicine 
packages. This is especially common for anti-retroviral medicines 
such as efavirenz, which is used for recreational purposes. This 
results in patients being denied their complete treatment regimen.
Student participants were concerned about the integrity of the 
medicines during the delivery process before the medicine parcel 
reached the patient. They suggested that one approach is to 
engage the aforementioned challenges with the role-players to 
arrive at a framework whereby there is reciprocal accountability 
and sharing of good pharmacy practice principles. This would 
require initiating a dialogue between medicine runners, 
pharmacists and patients, so that each role-player understands 
the importance of integrating medicine storage and delivery 
principles in community-based medicine access. 
Some CHF representatives seemed unsettled with the emergence 
of medicine runners, since they were traditionally responsible 
for assisting patients with queries at health facilities such as 
missing medicines in parcels and lost files. Inevitably, the trusting 
relationships between the community and CHF representatives 
that earned them the title of ‘foot soldiers’ for patients in the 
facilities, seemed to become sidelined with the introduction of 
medicine runners into the community skills mix. In essence, the 
CHF representatives felt alienated from discussions relating to the 
medicine runners’ introduction in the community. 
Lessons and questions
Post workshop, student discussions focused on pharmacy 
training (including campus teaching, SLiP and externship) and 
personal work experiences to make sense of the workshop 
themes by integrating it through a theory and practice lens. It 
was enlightening to witness the work of an alumnus expressing 
his entrepreneurial and innovative skills in improving medicine 
access in the community.
Upon reflecting on the pharmacist’s current role, there seems to 
be a position whereby services, which go beyond facility-based 
dispensing to working directly with communities, are required 
to seek solutions to address medicine access. The emergence of 
medicine runners in promoting access to medicine to chronic 
patients is a reality for those patients who are physically unable to 
collect their medicines at a specified date and time. A key question 
emerged: is facility-based dispensing data a reliable indicator to 
measure patient adherence to medicine regimens? It seems 
that roles and responsibilities between patients, pharmacists, 
medicine runners, and community health forum representatives 
should be outlined. This raises questions such as: should medicine 
runners be trained on basic pharmaceutical principles and who 
will be responsible for this training? Who is legally responsible for 
medicine delivery via unregulated medicine runners or courier 
services? How would medicine runners handle medicine queries 
from patients during the six-month period when there is no 
consultation with a pharmacist or healthcare professional?
A screening selection process for appointing medicine runners 
(either at the community level or within the health service) is 
necessary to eliminate the risk of substance abuse or theft. But, how 
and by whom should medicine runners be appointed to ensure 
responsible, safe and quality medicine delivery to underserved 
patients? The Iyeza Health® model might offer a framework 
which adheres to good pharmacy practice rules. A collaborative 
approach might answer questions about how medicine runners 
may be integrated into the health system to serve as a vehicle to 
improve adherence to medication and reduce the disease burden 
in low resource communities. And, while the service delivery fee 
might seem ‘reasonable’, how affordable is the delivery service 
within the poorer communities who are reliant on social grants as 
their only form of income?
The aforementioned questions then led the students to ask the 
main question: How should pharmacy training embed learning 
approaches to develop change agents/leaders who advocate for 
equitable medicine access for underserved communities? 
Key messages
• Despite the CCMDD programme launched by government, 
access to a continuous and reliable supply of chronic medicines 
remains a challenge in underserved communities. 
• Community-led solutions to medicine access, such as medicine 
runners, are evolving in parallel to facility-based pharmaceutical 
services.
• Meaningful engagement with key role players from across 
communities, service providers, institutions and organisations 
is crucial in ensuring the quality of medicines which are 
distributed to the community.
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• Pharmacy education may contribute towards community-based 
primary care services, by facilitating collective engagement 
between communities, students, pharmacy services and role-
players to address equitable access to medicines. Such an 
initiative would fulfil an NHI requirement.
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